A platform using matched patient-derived lung tumouroids and healthy lung organoids enables accurate examination of patient responses to CAR T therapy and offers a faithful framework for improved CAR T design.
- Lukas Ehlen
- Martí Farrera-Sal
- Michael Schmueck-Henneresse